Caplin Point Laboratories Ltd (BOM:524742)
₹ 1380.4 -18.05 (-1.29%) Market Cap: 104.83 Bil Enterprise Value: 96.49 Bil PE Ratio: 22.99 PB Ratio: 4.53 GF Score: 98/100

Q1 2024 Caplin Point Laboratories Ltd Earnings Call Transcript

Aug 08, 2023 / 05:30AM GMT
Release Date Price: ₹996.05 (+11.11%)
Operator

Ladies and gentlemen, good day, and welcome to the Caplin Laboratories Limited Q1 FY '24 Conference Call hosted by Dolat Capital. (Operator Instructions). Please note that this conference is being recorded.

I now hand the conference over to Ms. Rashmi Shetty from Dolat Capital. Thank you, and over to you, ma'am.

Rashmi Shetty

Thank you, and good morning, everyone. I'm Rashmi Shetty, Healthcare Analyst from Dolat Capital, extend a warm welcome to everyone joining us today to discuss Q1 FY '24 Earnings con call of Caplin Point Laboratories. On this call, we have with us Mr. C. C. Paarthipan, Chairman; Mr. Vivek Partheeban, COO; Dr. Sridhar Ganesan, Managing Director; Mr. Muralidharan, CFO; and Mr. Sathya Narayanan, Deputy CFO. Over to you, sir.

Partheeban Vivek Siddarth
Caplin Point Laboratories Limited - COO

Thank you, Rashmi. So hello, and good morning to everyone. Welcome to our earnings call to discuss the results of Q1 of FY'23, '24. Please note that a copy of all our disclosures are available on the Investors

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot